PMID- 35368974
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220405
IS  - 2470-752X (Electronic)
IS  - 2470-7511 (Print)
IS  - 2470-7511 (Linking)
VI  - 6
IP  - 4
DP  - 2021 Oct 1
TI  - Challenges in management of ST elevation myocardial infarction during COVID-19 
      pandemic.
PG  - 218-230
LID - 10.4103/2470-7511.334400 [doi]
AB  - The coronavirus disease-2019 (COVID-19) pandemic has brought unprecedented 
      changes to our world and health-care system. Its high virulence and 
      infectiousness directly infect people's respiratory system and indirectly disrupt 
      our health-care infrastructure. In particular, ST elevation myocardial infarction 
      (STEMI) is a clinical emergency emphasizes on the establishment of care system to 
      minimize delay to reperfusion. As such, the impact of COVID-19 on STEMI care, 
      ranging from disease severity, patient delay, diagnostic difficulty, triage to 
      selection of reperfusion strategy and postoperative care, is immense. 
      Importantly, not only we have to save our patients, but we must also need to 
      protect all health-care workers and prevent environmental contamination. 
      Otherwise, in-hospital transmission can quickly evolve into nosocomial outbreak 
      with staff infection and quarantine which lead to health-care system collapse. In 
      this article, we will discuss the challenges in various aspects of STEMI 
      management during COVID-19, as well as the mitigation measures we can take to 
      optimize outcome and our future.
CI  - Copyright (c) 2021 Cardiology Plus. Published by Wolters Kluwer - Medknow.
FAU - Tam, Chor-Cheung Frankie
AU  - Tam CF
AD  - Department of Medicine, Division of Cardiology, Queen Mary Hospital, The 
      University of Hong Kong, Hong Kong.
FAU - Siu, Chung-Wah David
AU  - Siu CD
AD  - Department of Medicine, Division of Cardiology, Queen Mary Hospital, The 
      University of Hong Kong, Hong Kong.
FAU - Tse, Hung Fat
AU  - Tse HF
AD  - Department of Medicine, Division of Cardiology, Queen Mary Hospital, The 
      University of Hong Kong, Hong Kong.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20211230
PL  - United States
TA  - Cardiol Plus
JT  - Cardiology plus
JID - 101772864
PMC - PMC8951676
OTO - NOTNLM
OT  - COVID-19
OT  - Percutaneous coronary intervention
OT  - ST-elevation myocardial infarction
COIS- There are no conflicts of interest.
EDAT- 2022/04/05 06:00
MHDA- 2022/04/05 06:01
PMCR- 2021/12/30
CRDT- 2022/04/04 05:15
PHST- 2021/09/15 00:00 [received]
PHST- 2021/12/06 00:00 [accepted]
PHST- 2022/04/04 05:15 [entrez]
PHST- 2022/04/05 06:00 [pubmed]
PHST- 2022/04/05 06:01 [medline]
PHST- 2021/12/30 00:00 [pmc-release]
AID - 10.4103/2470-7511.334400 [doi]
PST - ppublish
SO  - Cardiol Plus. 2021 Oct 1;6(4):218-230. doi: 10.4103/2470-7511.334400. Epub 2021 
      Dec 30.